Arq Inc
Arq Inc is a chemical company that operates in the commodity chemicals industry, producing and selling chemical products for industrial applications.
Business. Arq Inc (ARQ.O) is a commodity chemicals company listed on the NASDAQ. The firm operates within the Basic Materials sector, specifically focusing on the Chemicals industry group. The company generates revenue through a model combining volume and price for commodity grades with specialty premiums for branded formulations. Specific details regarding operating segments, headquarters location, and geographic mix are not provided in the available data.
Analyst recommendations
5 analysts · consensus BuyAt a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Company
- EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Arq Inc (ARQ.O) is a commodity chemicals company listed on the NASDAQ. The firm operates within the Basic Materials sector, specifically focusing on the Chemicals industry group. The company generates revenue through a model combining volume and price for commodity grades with specialty premiums for branded formulations. Specific details regarding operating segments, headquarters location, and geographic mix are not provided in the available data.
Arq Inc's capital structure is characterized by a low debt-to-equity ratio of 0.17, indicating a conservative leverage position relative to its equity base. The company's liquidity position is assessed as medium, with a current ratio of 1.04 and negative free cash flow of -$49.97 million, suggesting potential short-term liquidity constraints. The price-to-book ratio of 0.67 implies that the company's market value is trading at a discount to its book value, which may reflect market concerns about its current profitability and future prospects.
Profitability metrics for Arq Inc are weak, with a return on equity of -31.32% and a return on assets of -22.82%, both significantly below industry norms for commodity chemicals firms. The company reported a net loss of $52.61 million and an operating loss of $52.27 million, indicating a challenging operating environment. Gross profit of $33.53 million on $120.34 million in revenue suggests a gross margin of approximately 27.86%, which is below the typical gross margin for firms in the commodity chemicals industry.
Arq Inc's revenue is concentrated in a single business segment, with no disclosed geographic diversification in the provided data. This lack of diversification increases the company's exposure to regional economic fluctuations and industry-specific risks. The company's capital expenditures of -$9.11 million indicate a reduction in investment in long-term assets, which may signal a strategic shift or financial constraints.
The company's growth trajectory is uncertain, with no specific revenue growth projections provided in the data. However, the negative operating cash flow of -$2.73 million and the absence of positive earnings suggest a lack of momentum in revenue generation and cost control. The company's ability to improve its financial performance will depend on its capacity to reduce operating losses and enhance profitability.
Risk factors for Arq Inc include its negative net cash position after subtracting total debt, which could limit its ability to fund operations and invest in growth opportunities. The company's dilution risk is assessed as low, with no significant dilution potential identified in the data. However, the company's financial performance and liquidity position may necessitate future capital raising activities, which could lead to share dilution.
Recent events and disclosures for Arq Inc include analyst price targets ranging from $3.00 to $6.50, with a mean price target of $4.20 and a median price target of $3.50. The mean recommendation from analysts is 1.80, indicating a generally positive outlook, with one strong-buy recommendation and four buy recommendations. These analyst sentiments suggest that while there is optimism about the company's potential, the current financial performance and market conditions present significant challenges.
- Arq Inc is operating at a net loss with a return on equity of -31.32% and a return on assets of -22.82%.
- The company's liquidity position is medium, with a current ratio of 1.04 and negative free cash flow of -$49.97 million.
- Arq Inc's revenue is concentrated in a single business segment, increasing its exposure to industry-specific risks.
- Analysts have a generally positive outlook, with a mean price target of $4.20 and a median price target of $3.50.
- The company's capital expenditures have decreased, indicating a potential strategic shift or financial constraints.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
| Metric | Our forecast | Guidance | Consensus |
|---|---|---|---|
| EPS | —no estimate | —no estimate | -0,08 |
| Revenue | —no estimate | —no estimate | 123,7M USD |
| Operating income | —no estimate | —no estimate | 1,8M USD |
Options
Short squeeze
Earnings-call key lines
Consensus distribution
sell-side coverageEstimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Derivative transactions
- Chief Operating Officer · Performance Share Units → Common StockDisposed 102 934exercise · 2026-02-27
- Chief Technology Officer · Performance Share Units → Common StockDisposed 60 450exercise · 2026-02-27
- Gen Counsel, Corp Secretary · Performance Share Units → Common StockDisposed 42 358exercise · 2026-02-27
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Return On Equitynet_income / total_equity
- Price To Bookmarket_price / (adjusted_book_value / shares_outstanding_diluted)
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- Market Capmarket_price * shares_outstanding_diluted
- Ev To Revenueenterprise_value / revenue
- Arq Inc Market data — financials · 2026-05-27
- Arq Inc Market data — analyst estimates · 2026-05-27
- Arq Inc Market data — ESG · 2026-05-27
Ownership & reference
Top holders
- Investment Managers · as of 2026-03-310,00 %$3M
- Investment Managers · as of 2024-12-310,00 %$2M
- Investment Managers · as of 2026-03-310,00 %$2M
- Investment Managers · as of 2024-06-300,00 %$10M
- Investment Managers · as of 2026-03-310,00 %$2M
- Investment Managers · as of 2025-12-310,00 %$6M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$1M
- Investment Managers · as of 2026-03-310,00 %$1M
- Investment Managers · as of 2026-03-310,00 %$0M
- Institutional Investor · as of 2026-03-310,00 %$0M
- Institutional Investor · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Funds · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Brokerage Firms · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Institutional Investor · as of 2026-03-310,00 %$0M
Leadership
- Robert E. RasmusPresident, Chief Executive Officer, Director
Insider activity
- Chief Financial Officer · Common StockSold 16 709 @ $2,27$38K · 2026-05-04
- Chief Accounting Officer · Common StockOther 8 894 @ $2,27$20K · 2026-03-23
- Gen Counsel, Corp Secretary · Common StockOther 8 025 @ $2,27$18K · 2026-03-23
- Chief Technology Officer · Common StockOther 10 085 @ $2,27$23K · 2026-03-23
- Director, Chief Executive Officer · Common StockOther 845 @ $2,27$2K · 2026-03-23
- Director · Common StockBought 150 000 @ $2,21$332K · 2026-03-23
- Chief Technology Officer · Common StockBought 10 000 @ $1,89$19K · 2026-03-17
- Gen Counsel, Corp Secretary · Common StockBought 1 000 @ $1,92$2K · 2026-03-16
- Director · Common StockBought 77 500 @ $1,95$151K · 2026-03-13
- Gen Counsel, Corp Secretary · Common StockBought 1 000 @ $1,92$2K · 2026-03-12
- Chief Technology Officer · Common StockOther 17 338 @ $3,51$61K · 2026-02-27
- Chief Technology Officer · Common StockOther 40 286 · 2026-02-27
- Gen Counsel, Corp Secretary · Common StockOther 28 229 · 2026-02-27
- Gen Counsel, Corp Secretary · Common StockOther 10 176 @ $3,51$36K · 2026-02-27
- Chief Operating Officer · Common StockOther 68 600 · 2026-02-27
- Chief Operating Officer · Common StockOther 18 282 @ $3,51$64K · 2026-02-27
- Chief Financial Officer · Common StockBought 6 000 @ $3,55$21K · 2025-11-11
- Director · Common StockBought 28 638 @ $3,54$101K · 2025-11-11
- Director, Chief Executive Officer · Common StockBought 50 000 @ $3,79$190K · 2025-11-10
- Chief Financial Officer · Common StockBought 9 000 @ $3,74$34K · 2025-11-10
- Director · Common StockOther 30 000 · 2025-09-25
- Chief Operating Officer · Common StockOther 2 029 @ $7,00$14K · 2025-09-18
- Chief Operating Officer · Common StockSold 1 782 @ $5,20$9K · 2025-08-04
- Chief Technology Officer · Common StockSold 3 052 @ $5,20$16K · 2025-08-04
- Gen Counsel, Corp Secretary · Common StockSold 2 591 @ $5,20$13K · 2025-08-04
Short positioning
Geographic breakdown
Intel & risk
Evidence & claims
From filings & derived data- Cash & equivalents (YoY) (2025-12-31 vs 2024-12-31): -51.4%Derived (calculated)
- Operating cash flow (YoY) (2025-12-31 vs 2024-12-31): -126.1%Derived (calculated)
- Operating income (YoY) (2025-12-31 vs 2024-12-31): -2,603.3%Derived (calculated)
- R&D expense (YoY) (2025-12-31 vs 2024-12-31): 81.2%Derived (calculated)
- Shareholders' equity (YoY) (2025-12-31 vs 2024-12-31): -22.7%Derived (calculated)
- Total assets (YoY) (2025-12-31 vs 2024-12-31): -18.9%Derived (calculated)
- Total liabilities (YoY) (2025-12-31 vs 2024-12-31): -6.7%Derived (calculated)
- Net income (YoY) (2025-12-31 vs 2024-12-31): -929.8%Derived (calculated)
- Debt-to-equity (FY 2025-12-31): 0.37xDerived (calculated)
- Cost of revenue (YoY) (2025-12-31 vs 2024-12-31): 24.9%Derived (calculated)
- Long-term debt (YoY) (2025-12-31 vs 2024-12-31): 14.4%Derived (calculated)
- Current ratio (FY 2025-12-31): 1.04xDerived (calculated)
- Return on assets (FY 2025-12-31): -22.8%Derived (calculated)
- Return on equity (FY 2025-12-31): -31.3%Derived (calculated)
- EPS (diluted) (YoY) (2025-12-31 vs 2024-12-31): -807.1%Derived (calculated)
- EPS (basic) (YoY) (2025-12-31 vs 2024-12-31): -807.1%Derived (calculated)
- EPS (basic) (annual): USD-PER-SHARES -1SEC XBRL filing
- Cost of revenue (annual): USD 86.8MSEC XBRL filing
- Current assets (annual): USD 43.85MSEC XBRL filing
- Operating income (annual): USD -52.96MSEC XBRL filing
- R&D expense (annual): USD 7.34MSEC XBRL filing
- Net income (annual): USD -52.61MSEC XBRL filing
- Current liabilities (annual): USD 42.3MSEC XBRL filing
- Operating cash flow (annual): USD -2.73MSEC XBRL filing